SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

SRPT Sarepta Therapeutics appoints Michael severino, M.D., Chief Executive Officer Sarepta Therapeutics - Doug ingram to retire and serve as

SRPT Sarepta Therapeutics appoints Michael severino, M.D., Chief Executive Officer Sarepta Therapeutics - Doug ingram to retire and serve as advisor until end of 2026

SRPT

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.